Shinya Nakada

Thesis title: Mental health conditions and cardiovascular diseases: association and risk stratification based on genetics, lifestyle, and biomarkers

Biography

Qualifications

2020-2021    Master of Public Health, University of Glasgow

2009-2013    Bachelor of Nursing,  Chiba Prefectural University of Health Sciences, Japan

Responsibilities & affiliations

  • Clinical Practice Research Datalink nominated data user, School of Health and Wellbeing, College of Medical, Veterinary and Life Science, University of Glasgow, 2025
  • Postgraduate research student representative, School of Health and Wellbeing, College of Medical, Veterinary and Life Science, University of Glasgow, 2025

Research summary

I aim to integrate complementary disciplines— epidemiology, data science, and molecular biology—into a cohesive translational research programme that generates actionable insights, thereby reducing the global burden of mental and cardiovascular health problems across life stages.

 

Conference details

  • SCORE2 underestimates the risk of cardiovascular disease among people with depression and anxiety disorder, European Society of Cardiology Preventive Cardiology, Poster presentation, 2025
  • Refining the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations using depression and anxiety disorder, American Heart Association Scientific Sessions 2024, Moderated digital poster presentation, 2024
  • Anxiety disorder, depression and coronary artery disease: associations and modification by genetic susceptibility, American Heart Association Scientific Sessions 2024, Moderated digital poster presentation, 2024
  • Refining the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations using depression and anxiety disorder, The Equity in Equations Symposium in American Heart Association Scientific Sessions 2024, Poster presentation, 2024
  • Shared and distinct pathways from anxiety disorder and depression to cardiovascular disease: a mediation analysis of the UK Biobank prospective cohort study, European Society of Cardiology Preventive Cardiology, Poster presentation, 2024
  • Shared and distinct pathways from anxiety disorder and depression to cardiovascular disease: a mediation analysis of the UK Biobank prospective cohort study, Scotland's Health Research and Innovation Conference, Poster presentation, 2023

Invited speaker

• Refining the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations using depression and anxiety disorder, Glasgow Clinical Academic Research Prize Night, Oral presentation, 2024

• Birth weight, metabolic syndrome, and cardiovascular disease, DOHaD academic conference in Japan, 2023

  • Nakada S et al. Circulating metabolites in adolescence associated with clinical obesity in young adulthood. European Journal of Internal Medicine. 2026 August  DOI: 10.1016/j.ejim.2026.107134.
  • Lithgow H, Johnston L, Ho F, Nakada S et al.　The effects of vitamin K2 on recovery from muscle damaging resistance exercise in young and older adults – The TAKEOVER randomised controlled trial. Science in Sports and Exercise, DOI: 10.1249/MSS.0000000000003901
  • Nakada S et al. Shared and distinct pathways from anxiety disorder and depression to cardiovascular disease: a mediation analysis of the UK Biobank prospective cohort study. European Journal of Preventive Cardiology 2025. DOI: 10.1093/eurjpc/zwaf110
  • Nakada S et al. Anxiety disorder, depression and coronary artery disease: associations and modification by genetic susceptibility. BMC Med 2025-2. DOI: 10.1186/s12916-025-03915-4
  • Nakada S et al. Refining PREVENT prediction models for 10-year risk of cardiovascular disease using measures of anxiety and depression. CMAJ 2025 January 13;197:E1­8. doi: 10.1503/cmaj.240996
  • Nakada S et al. Hospital admissions for anxiety disorder, depression, and bipolar disorder and venous thromboembolism: A UK biobank prospective cohort study, J Affect Disord. 2024-12. DOI: 10.1016/j.jad.2024.12.060
  • Ho F; Dale C; Mizani M; Bolton T; Pearson R; Valabhji J; Delles C; Welsh P; Nakada S et al. Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study. PLOS Medicine. 2024-11. DOI:10.1371/journal.pmed.1004485
  • Nadaraia T; Whittaker E; Kenyon I; Boonpor J; Zhou Z; Nakada S et al. Childhood maltreatment, adulthood obesity and incident type 2 diabetes: a retrospective cohort study using UK Biobank. International Journal of Obesity. 2024-02. DOI:10.1038/s41366-024-01652-x
  • Nakada S et al.  Schizophrenia and Types of Stroke: A Mendelian Randomization Study. Journal of the American Heart Association. 2024-02-29. DOI: 10.1161/JAHA.123.032011
  • Nakada S et al. Individual and joint associations of anxiety disorder and depression with cardiovascular disease: A UK Biobank prospective cohort study. European Psychiatry. 2023. DOI: 10.1192/j.eurpsy.2023.2425
  • Yoshii K; Morisaki N; Piedvache A; Nakada S et al. Association between birth weight and prevalence of cardiovascular disease and other lifestyle-related diseases among Japanese population: JPHC-NEXT Study. Journal of Epidemiology. 2023. DOI: 10.2188/jea.JE20230045
  • Ho F; Wirth M; Soto S; Boonpor J; Zhou Z; Rocha F; Nakada S et al. Dose-Response Associations of Dietary Inflammatory Potential With Health Outcomes: A Prospective Cohort Study of 198,265 UK Biobank Participants. Current Problems in Cardiology. 2023-09. DOI: 10.1016/j.cpcardiol.2023.101774
  • Nakada S et al. Association between being breastfed and cardiovascular disease: a population cohort study of 320 249 participants. Journal of Public Health. 2023-08-28. DOI: 10.1093/pubmed/fdad016
This article was published on